mountain.jpg
 

personal diagnostics

Growth of miniaturized devices along with wireless communication tools have fundamentally changed the structure of how we connect. In order for proper healthcare to be more attainable and efficient, technological innovation and tools must similarly be made available. We believe that structural change in basic healthcare delivery begins with personal diagnostics.

 

rHEALTH and XPRIZE

We embarked on a mission to democratize biomedical diagnostics.  Early on, we had to explain to everyone why and the importance of what we were doing.  Today we don't.  This is in part due to XPRIZE's shared vision to create devices that push the technological capabilities of current diagnostics and bring them to consumers.

Strengthened through competitions

We believe that our technology cannot be good without extensive external testing against standards as well as other innovations.  And so, we deliberately pushed ourselves toward this activity in order to come to something that is valuable and useful. Throughout our participation in two XPRIZE competitions, the $2.25M Nokia Sensing XChallenge and the $10M Tricorder XPRIZE, our team and technology had to meet numerous deadlines, milestones, technology demonstrations, laboratory standards, and user experience criteria. In aggregate, the stringent requirements has given us invaluable experience, technology edge, and a core team dedicated to make this happen.

Personal diagnostics will unfold gradually, in a disease- and indication-focused manner.   After successful participation in competition, we are in the unique position to make  our solutions broadly available to help increase society's access to healthcare. 

A view towards the future

The future is what you make of it.  This is firmly what we and XPRIZE believe.  In fact, the competition introduced to the word, "visioneering," which is a portmanteau of vision and engineering. The competition goals were meant to be visionary, a guidepost for what the future may look like 10-20 years down the road. Our involvement had provided us the perspective to put the rHEALTH to work.

We are committed to deliver the next generation of the rHEALTH®  system into the hands of consumers. It's about managing health and disease better and it begins with an integrated system that can sense the internal indicators. Our solution offers what has been missing in the wearable and digital health revolutionprecision, biochemical blood-diagnostics.


 
 

In many countries, mechanisms for laboratory standard testing are in short supply. Even for developed countries with admirable healthcare infrastructures access may often not be timely, convenient, cost-effective, or reliable. The goal of the NSXC was to accelerate the availability of sensing technology for faster and easier means to get valuable health information that has been limited by the capacity of conventional testing.  The rHEALTH®  ONE was the Grand Prize Winner in the second round of this competition.

  Left.  The rHEATH®  ONE, is a microvolume, biomarker analyzer with exquisite sensitivity and diverse applications.  Right.  Consumable. Device is limited by FDA regulation for research or investigational purposes only. 

Left. The rHEATH®  ONE, is a microvolume, biomarker analyzer with exquisite sensitivity and diverse applications. Right. Consumable. Device is limited by FDA regulation for research or investigational purposes only. 


 
 

Few methods exist for consumers to receive direct medical care without seeing a healthcare professional at a clinic or hospital. The QTXP competition sought to address this access bottleneck. The goal of the competition is to develop a consumer-user device that is capable of diagnosing a set of 13 health conditions while also capturing key health metrics for any given user.  The solutions enable consumers in any location to quickly and effectively evaluate health conditions.  Our technology was one of five Finalists from over 300 teams worldwide based on judging, lab and consumer testing.

 

blue_background.png
 

 watch our story...

 

*Device is limited by FDA regulation for research or investigational purposes only.